Rare and Ultra-Rare Bleeding Disorders

Rare and Ultra-Rare Bleeding Disorders

While haemophilia and von Willebrand disease are the most widely recognised inherited bleeding disorders, several rare and ultra-rare bleeding conditions can also affect the body’s ability to stop bleeding. These disorders occur when one of the proteins or cells involved in blood clotting does not function correctly. In many cases, this means a specific clotting factor is missing or defective, or the platelets that help form blood clots do not work properly. Although rare, these conditions can cause significant bleeding symptoms and require specialised care from healthcare professionals experienced in managing bleeding disorders. Patients are often treated at Haemophilia Treatment Centres (HTCs) where multidisciplinary teams provide diagnosis, treatment, and long-term management.

Most rare bleeding disorders are inherited genetic conditions caused by mutations in the genes responsible for producing clotting proteins or platelet function.

In many cases:

  • The condition follows an autosomal recessive inheritance pattern
  • Both parents carry the gene, even if they do not have symptoms
  • A child must inherit the altered gene from both parents to develop the disorder

Some bleeding disorders may also develop later in life due to autoimmune conditions, medications, liver disease, or other medical factors, but inherited disorders are the most common.

Symptoms vary depending on the specific disorder and the severity of the deficiency. Common signs include:

  • Frequent nosebleeds

  • Easy bruising

  • Prolonged bleeding after injury or surgery

  • Heavy menstrual bleeding

  • Gum bleeding

  • Bleeding into muscles or joints

  • Excessive bleeding after dental procedures

  • Bleeding in newborns

Severe cases may involve internal bleeding, which requires urgent medical attention.

Diagnosis usually involves specialised testing, including:

  • Medical and family history evaluation

  • Blood clotting tests

  • Specific clotting factor assays

  • Platelet function testing

  • Genetic testing when necessary

Because these disorders are rare, diagnosis is often made at specialised laboratories associated with haemophilia treatment centres.

Treatment depends on the specific disorder and the severity of bleeding symptoms. Management may include:

  • Clotting factor replacement therapy

  • Platelet transfusions

  • Fresh frozen plasma (FFP)

  • Cryoprecipitate

  • Antifibrinolytic medications

  • Preventative treatment before surgery or dental procedures

With proper treatment and monitoring, many people living with rare bleeding disorders can lead active and healthy lives.

Types of Rare Bleeding Disorders

Below are several rare bleeding disorders caused by deficiencies in clotting factors or platelet function.

Fibrinogen helps form the final clot that stops bleeding.

Forms include:

  • Afibrinogenemia – absence of fibrinogen

  • Hypofibrinogenemia – low levels of fibrinogen

  • Dysfibrinogenemia – fibrinogen that does not function properly

Symptoms may include severe bleeding, umbilical cord bleeding in newborns, and bleeding after injury or surgery.

Treatment may include fibrinogen concentrates, cryoprecipitate, or plasma therapy.

Factor II (prothrombin) plays a key role in generating thrombin, an enzyme necessary for clot formation.

Symptoms may include:

  • Easy bruising

  • Nosebleeds

  • Bleeding after surgery or injury

  • Heavy menstrual bleeding

Treatment often includes prothrombin complex concentrates or plasma therapy.

Also known as Owren’s disease, this condition causes reduced clotting ability.

Symptoms include:

  • Frequent nosebleeds

  • Gum bleeding

  • Easy bruising

  • Prolonged bleeding after injury

Treatment generally involves fresh frozen plasma to replace the missing factor.

Factor VII deficiency is the most common of the rare clotting factor deficiencies, though still uncommon.

Symptoms may include:

  • Nosebleeds

  • Heavy menstrual bleeding

  • Joint bleeding

  • Muscle bleeding

Treatment options may include recombinant Factor VIIa or plasma therapy, especially before surgery.

Factor X plays an essential role in the clotting cascade, helping generate thrombin.

Symptoms may include:

  • Easy bruising

  • Nosebleeds

  • Joint bleeding

  • Bleeding after trauma or surgery

Treatment options include Factor X concentrate or plasma therapy.

Factor XI deficiency is sometimes called Hemophilia C.

Unlike haemophilia A and B, spontaneous bleeding is less common. Bleeding usually occurs after injury or surgery.

Symptoms may include:

  • Excessive bleeding after surgery

  • Nosebleeds

  • Heavy menstrual bleeding

Treatment may include antifibrinolytic medicines or plasma therapy.

Factor XIII stabilizes blood clots after they form.

Symptoms can include:

  • Delayed bleeding after injury

  • Poor wound healing

  • Bleeding in newborns

  • Recurrent miscarriage in women

Severe cases may lead to life-threatening bleeding in the brain.

Treatment usually involves regular Factor XIII replacement therapy.

Glanzmann Thrombasthenia is a rare inherited platelet disorder in which platelets cannot properly stick together to form a clot.

Unlike clotting factor deficiencies, this condition affects platelet function rather than clotting proteins.

Symptoms may include:

  • Frequent nosebleeds

  • Gum bleeding

  • Easy bruising

  • Heavy menstrual bleeding

  • Prolonged bleeding after injury or surgery

Treatment may involve:

  • Platelet transfusions

  • Antifibrinolytic medications

  • Recombinant factor VIIa in certain situations

Care is usually coordinated through specialised haemophilia treatment centres.

Living with a Rare Bleeding Disorder

With proper medical care and support, people with rare bleeding disorders can lead healthy and active lives.

  • Regular visits with a haematologist
  • Monitoring bleeding symptoms
  • Planning treatment before surgeries or dental procedures
  • Education about recognising bleeding complications
  • Access to patient support organisations

The South African Haemophilia Foundation (SAHF) supports patients and families by providing education, advocacy, and resources to improve access to care.